Vetrepharm ApS: Financial statements 2013
CVR: 15206802
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Vetrepharm ApS (CVR 15206802) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 1,070,317 and a net result of DKK 465,793 compared with DKK 289,138 the year before. That is an increase of 3.9% compared with the year before. Equity in the 2013 report amounted to DKK 1,393,293. The solvency ratio was 61.7%.
- Gross Profit
- DKK 1,070,317
- Profit/Loss
- DKK 465,793
- Equity
- DKK 1,393,293
- Total Assets
- DKK 2,257,010
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 1.1 mio. | 466 t. | 1.4 mio. | - |
| 2012 | - | 1 mio. | 289 t. | 1.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
Vetrepharm ApS has published its annual report for 2012. Gross profit came to DKK 1,030,294, and the net result was DKK 289,138.
As of April 13, 2013, G.S.REVISION A/S, REG. REVISIONSSELSKAB has stepped down as auditor of Vetrepharm ApS.
About Vetrepharm ApS
Vetrepharm ApS was a Danish company of the type Anpartsselskab based in Brande, founded in 1991. The company has been dissolved on 4 October 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETREPHARM A/S and A/S PSE NR. 4365. The company has 1 employee (2020). In 2019, the company reported a gross profit of DKK -39,654 and a net result of DKK -84,121 compared with DKK -199,932 the year before. Equity in the 2019 report amounted to DKK -14,643.